Home – Vitae Pharmaceuticals #safc #pharma

Posted On Jan 8 2017 by

#new pharmaceuticals # Developing New Therapies for Diseases with Significant Unmet Medical Needs Vitae Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering and developing novel, small molecule drugs for diseases with significant unmet medical needs.The company leverages its structure-based drug design platform, Contour®, creating a robust and growing portfolio of product candidates. Vitae Pharmaceuticals is developing and plans to commercialize multiple product candidates including its innovative RORγt program to treat various autoimmune diseases. Vitae Pharmaceuticals develops drugs for “difficult-to-drug” targets. Click to learn more. Vitae Pharmaceuticals has developed proprietary expertise in structure-based drug design (SBDD). The clinical stage …


Pharma newsletter #pharmaceutical #industry #growth

Posted On Jan 8 2017 by

#pharma newsletter # WHO Pharmaceuticals Newsletter The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of “drug information officers” and other sources such as specialized bulletins and journals. The information is produced in the form of résumés in English. To receive the newsletter by e-mail 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Newsletter No. 6 pdf, 317kb Newsletter No. 5 pdf, 359kb Newsletter No. 4 pdf, 264kb Newsletter No. 3 pdf, 216kb Newsletter No. 2 pdf, 518kb Newsletter No. 1 pdf, 352kb …


Actavis Pharma Manufacturing Ltd: Latest News – Videos, Photos about Actavis Pharma Manufacturing Ltd #pharmaceutical

Posted On Jan 8 2017 by

#actavis pharma manufacturing # ACTAVIS PHARMA MANUFACTURING LTD #LeanIn: Maternity Bill passed in RS, now women to get 6 months off While India was rooting for PV Sindhu, Andhra Pradesh and Telangana were googling her caste The wait is over: iPhone 7 is coming soon Centre returns bill for 400 per cent hike in Delhi MLA salaries Price war: Idea, Vodafone and Bharti Airtel to slash tariffs to compete with Reliance Jio Can football help you build your portfolio? ‘No chance’ of returning to the family business, says Onida Group’s Sasha Mirchandani Best 13-inch laptops of the year How to …


Pharmaceutical companies in new york #pharma #distributors

Posted On Jan 8 2017 by

#pharmaceutical companies in new york # Athenex Announces the Addition of James Hussey to Lead its Commercial Business Activities Athenex announced today that James Hussey has joined the Company as Executive Vice President of Athenex Pharmaceutical Division. In this capacity, Mr. Hussey will be responsible for the execution of the commercial aspects of this business unit including strategy, new products, manufacturing, distribution, sales and marketing. Governor Cuomo Announces Major Expansion of Athenex Creating 1,400 Jobs in Western New York Athenex (formerly Kinex) to invest $1.62 billion in drug discovery and advanced manufacturing partnership, creating 900 jobs in Dunkirk and 500 …


Actavis Pharma, Inc #pharma #dynamics

Posted On Jan 8 2017 by

#actavis pharma manufacturing # Actavis Pharma, Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page …